The correlation of AQP3 and AQP5 with EMT and tumorigenesis has also been reported in triple-negative breast cancer and hepatocellular carcinoma patients, suggesting the potential of AQP3 and AQP5 as prognostic and therapeutic markers [31,75]. This evidence concerns the gene AQP3 and hepatocellular carcinoma.